Posted on 6/24/20
Medical Economics Named National and Regional Winner of 2020 Azbee Awards of Excellence
CRANBURY, N.J.--(BUSINESS WIRE)--Medical Economics, a multimedia platform that provides resources for physicians that include practice management tips, health technology and expert voices, announces that its article . . .
Posted on 6/24/20
AsclepiX Therapeutics Raises $35M Series A
AsclepiX Therapeutics, Inc., a biopharmaceutical company that uses computational biology to identify potent peptide regulators of vascular homeostasis for the treatment of retinal and other important . . .
Posted on 6/23/20
IVERIC bio Announces Closing of Public Offering
NEW YORK--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE), today announced the closing of its underwritten public offering of 28,503,220 shares of its common stock at a price . . .
Posted on 6/23/20
Stellar Health and Accurate Diagnostic Laboratories Announce Strategic Collaboration
Stellar Health and Accurate Diagnostic Laboratories are pleased to announce a collaboration to align their efforts around the mission of assisting health care providers to keep patient . . .
Posted on 6/23/20
TARA Biosystems Announces $10 Million Series A2 Financing
TARA Biosystems, Inc., a company generating in vitro human biology to increase the success of cardiac disease drug discovery and development, today announced a $10 million . . .
Posted on 6/23/20
Outlook Therapeutics Announces $11.2 Million Financings
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation
Posted on 6/23/20
States that Have the Fewest Coronavirus Restrictions – Updated WalletHub Study
With all states gradually reopening but monitoring for any spikes in COVID-19 cases that would impact their reopening plans, the personal-finance website WalletHub today released updated . . .
Posted on 6/23/20
Better Buy: Verizon Communications vs. Johnson & Johnson
Verizon Communications (NYSE:VZ) and Johnson & Johnson (NYSE:JNJ) are good defensive stocks for volatile markets. Verizon is the second-largest wireless carrier in the U.S. after AT&T . . .
Posted on 6/23/20
Novartis Shuts Down Hydroxychloroquine COVID-19 Clinical Trial
The rapid descent continues for hydroxychloroquine as hope for a cure for COVID-19. On Monday, pharmaceutical giant Novartis (NYSE:NVS) announced that it is stopping the sponsored . . .
Posted on 6/22/20
Provention Bio Closes Public Offering of Common Stock
Provention Bio, Inc., (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced today the closing of the previously announced public offering of . . .
Posted on 6/22/20
Regeneron Announces the 2020 Winners of the Regeneron Prize for Creative Innovation
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the eighth annual Regeneron Prize for Creative Innovation, which celebrates and rewards cutting-edge thinking from the . . .
Posted on 6/22/20
Athenex Announces $225 Million Loan Agreement with Oaktree
BUFFALO, N.Y., June 22, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies . . .
Posted on 6/22/20
Evergreen Theragnostics Completes $19 Million Series A
Evergreen Theragnostics, Inc., a radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced that it has raised $19M in a Series A financing round.
Posted on 6/22/20
Better Buy: Novartis vs. Teva Pharmaceutical
Novartis (NYSE:NVS) and Teva Pharmaceutical (NYSE:TEVA) are two very well-known names in the big pharma space. Shares for both companies have recovered well since their lows . . .
Posted on 6/21/20
Celldex Therapeutics Prices $130.4M Public Offering of Common Stock
HAMPTON, N.J., (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq: CLDX), today announced the pricing of its previously announced underwritten public offering. Celldex is offering 13,377,926 shares of . . .
Posted on 6/21/20
Royalty Pharma Prices IPO
NEW YORK, (GLOBE NEWSWIRE) -- Royalty Pharma plc today announced the pricing of the initial public offering of 77,681,670 shares of its Class A ordinary shares . . .
Posted on 6/21/20
Celldex Therapeutics Proposes Public Offering of Common Stock
HAMPTON, N.J., (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq: CLDX), today announced that it is proposing to offer and sell, subject to market conditions, shares of its . . .
Posted on 6/21/20
Agios and Royalty Pharma Announce $255M Purchase Agreement for IDHIFA Royalty
CAMBRIDGE, Mass. and NEW YORK (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare . . .
Posted on 6/21/20
Actinium Pharmaceuticals Closes $25M Public Offering
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) today announced the closing of its previously announced public offering of 76,923,077 shares of its common stock (or common stock . . .
Posted on 6/19/20
Better Buy: Pfizer vs. Merck
Pfizer (NYSE:PFE) and Merck (NYSE:MRK) are both multinational pharmaceutical heavyweights, complete with massive development pipelines, numerous subsidiaries, and consistently profitable operations. With nearly identical market caps . . .
Posted on 6/19/20
Pfizer and Sangamo's Gene Therapy Continues to Help Patients with Hemophilia in Clinical Trial
So far, so good for Pfizer (NYSE:PFE) and Sangamo Therapeutics' (NASDAQ:SGMO) gene therapy candidate, giroctocogene fitelparvovec, which the healthcare companies are developing for patients with hemophilia . . .
Posted on 6/19/20
Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals
Intercept Pharmaceuticals (NASDAQ:ICPT) and Madrigal Pharmaceuticals (NASDAQ:MDGL) are two stocks that have moved in opposite directions of late. Intercept's stock has slid by 36% since the . . .
Posted on 6/18/20
KORU Medical Commences Public Offering of Common Stock
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) today announced that it has commenced an underwritten public offering of the sale of . . .
Posted on 6/18/20
Provention Bio Announces Pricing of $95.7 Million Public Offering of Common Stock
Provention Bio, Inc., (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the pricing of its previously announced underwritten public offering . . .
Posted on 6/18/20
IVERIC bio Announces Pricing of Upsized Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE), today announced the pricing of an upsized underwritten public offering of 24,535,720 shares of its common stock at a . . .
New York
